Alexandria Real Estate, US0152711022

Why a biotech lab in Cambridge matters, Alexandria Real Estate Equities builds 300 Tech Square for science

17.06.2026 - 14:57:38 | ad-hoc-news.de

Alexandria Real Estate Equities leans into its lab-first model with 300 Tech Square in Cambridge, a dense, glassy research hub tailored for biotech teams that have outgrown generic offices. What the campus offers day to day - and why tenants pay up.

Alexandria Real Estate, US0152711022
Alexandria Real Estate, US0152711022

Reviewed: ad hoc news Accessory & Components desk. Edited and checked on 2026-06-17, 14:54. Details in the imprint.

With 300 Tech Square, Alexandria Real Estate Equities puts a glass-and-steel lab building right in the tight street grid of Cambridge, where researchers walk to work with coffee in hand and badge into floors that smell faintly of ethanol and fresh paint.

Go deeper

Background on the Alexandria Real Estate Equities stock

Alexandria Real Estate Equities focuses on life-science campuses like 300 Tech Square, and the stock reflects how strongly biotech tenants value purpose-built lab space.

What 300 Tech Square actually is

300 Tech Square is part of Alexandria’s flagship Alexandria Center at One Kendall Square campus in Cambridge, Massachusetts, one of the densest life-science clusters in the United States. It combines modern lab space with offices, meeting zones, and ground-floor amenities tailored to biotech teams.

The building sits a short walk from the Kendall/MIT subway stop, surrounded by research neighbors like MIT labs and other biotech offices, which keeps foot traffic high from early morning until late at night. Tenants essentially live in a science bubble where lab, lecture hall, and coffee shop blur together.

How the lab space feels in daily use

Inside, 300 Tech Square offers flexible lab layouts: long bench lines, ceiling space for ductwork, and heavy-duty floors that accept specialized equipment without feeling improvised. Researchers get wide corridors for moving gas bottles and freezers, instead of squeezing through retrofitted office hallways.

The ventilation and mechanical backbone are designed for wet labs, not adapted from a standard office tower, which means high air-change rates and space for fume hoods without constant compromises. For teams that have outgrown makeshift labs, that predictability is a quiet, daily relief.

Amenities that matter more than they sound

Beyond the lab floors, 300 Tech Square plugs into a campus that layers in cafés, informal meeting corners, and outdoor seating areas where teams debrief experiments or talk fundraising under trees rather than in windowless rooms. That sounds soft, but it shapes how people use the building.

Conference rooms and shared areas are wired for hybrid meetings, since many biotech firms now coordinate global clinical or regulatory teams. Good acoustics and clean sightlines help those calls feel less like a compromise and more like a normal part of the workday.

Who moves in, and why they stay

Alexandria markets 300 Tech Square to established and growth-stage life-science tenants that need both office and high-spec lab space in Cambridge’s Kendall Square. These are companies that may have started in incubators but now need their own floors, their own security, and room to grow.

Because the building is integrated into a larger campus, tenants can scale within the same neighborhood instead of uprooting when they hire their next hundred scientists. That continuity appeals to management, but it also appeals to staff who build routines around the commute and the local streets.

How it fits into Alexandria’s strategy

300 Tech Square is one tile in Alexandria’s broader mosaic of life-science campuses across U.S. innovation hubs, including Greater Boston, San Diego, and the San Francisco Bay Area. The company leans hard into a “cluster” strategy rather than scattered single assets.

For Alexandria, purpose-built lab campuses like this are meant to deliver more stable occupancy than generic offices, because wet labs are harder to relocate and require long-term planning. That stickiness is central to how the landlord positions itself with investors looking at recurring rental income.

Context for investors and listing

Alexandria Real Estate Equities focuses on life-science and technology campuses, with key properties in clusters such as Kendall Square and Mission Bay. Shares of Alexandria Real Estate Equities (US0152711022) trade on the New York Stock Exchange in U.S. dollars.

Key facts on 300 Tech Square

  • Product: 300 Tech Square
  • Manufacturer: Alexandria Real Estate Equities Inc.
  • Category: Accessory/Spare part (life-science campus building)
  • Launch: Existing property within Alexandria’s Kendall Square campus
  • RRP / Price: Not publicly marketed as a sale product, leased to tenants
  • Availability: Leased as lab and office space in Cambridge, Massachusetts, primarily to life-science tenants
  • Target group: Biotech and life-science companies needing high-spec laboratory and office space in Kendall Square
  • Highlight / USP: Purpose-built wet-lab infrastructure integrated into a dense, amenity-rich life-science campus

More impressions and opinions on 300 Tech Square

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.

en | US0152711022 | ALEXANDRIA REAL ESTATE | boerse | 69562766 | bgmi